Category: Providers

Breaking News

J&J Sues HRSA for Blocking Controversial 340B Rebate Model

November 12, 2024 William Newton, Associate Editor/Senior Writer Views

J&J is suing the federal government to implement the drugmaker's controversial 340B rebate proposal.

Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Proposition 34: Results Too Close to Call in Controversial California 340B Ballot Measure Contest

November 7, 2024 Shannon Young, Associate Editor/Senior Writer Views

California voters weighed-in on Proposition 34, a controversial 340B-related ballot measure in the Nov. 5 elections.

With just over half of the expected vote total counted, it’s too early to tell whether California voters will approve [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Officials, Providers Urge Supreme Court to Deny PhRMA’s Appeal to Overturn 340B Contract Pharmacy Access Law

November 7, 2024 William Newton, Associate Editor/Senior Writer Views

Attorneys for the state of Arkansas and local providers argued the Supreme Court should not take up PhRMA's appeal to overturn a state 340B law.

Arkansas state officials and providers are urging the U.S. Supreme Court not to take up a drug industry trade group’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri, Kansas

November 7, 2024 Shannon Young, William Newton and Bella Czajkowski, Associate Editor/Senior Writer Views

Key briefs were filed this week in state contract pharmacy litigation in West Virginia, Missouri and Kansas.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Major GPO Sues HRSA over Restrictions on How 340B Hospitals Purchase Initial Drug Inventory

November 5, 2024 William Newton, Associate Editor/Senior Writer Views

Premier, a major GPO, has sued HRSA over a policy restricting how hospitals can purchase initial physical drug inventory.

A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

BI Tightens Contract Pharmacy Restrictions for All Covered Entities

November 5, 2024 William Newton, Associate Editor/Senior Writer Views

Boehringer Ingelheim recently announced it will tighten its 340B contract pharmacy restrictions by requiring claims data submission.

Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Appeals Court Ruling That Blocked DSH Calculation Changes That Impact 340B Eligibility

October 31, 2024 Shannon Young, Associate Editor/Senior Writer Views

The 5th Circuit Court of Appeals will take up a case that Texas hospitals filed against HHS to block changes to how the Medicare DSH payment calculation is determined.

The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri – Oct 24

October 31, 2024 William Newton, Associate Editor/Senior Writer Views

Key briefs were filed this week in state contract pharmacy litigation in Arkansas and Missouri.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AstraZeneca Announces Change to Cancer Drug Replenishment After Discontinuing Certain Dosage

October 29, 2024 Bella Czajkowski, National Correspondent Views

AstraZeneca recently posted an NDC notice to 340B covered entities regarding replenishment of a cancer medication.

AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UCB Extends Contract Pharmacy Restrictions to All Federal Grantees

October 28, 2024 William Newton, Associate Editor/Senior Writer Views

UCB announced extended 340B contract pharmacy restrictions that will take effect Nov. 25.

Belgium pharmaceutical giant UCB is extending its 340B contract pharmacy restrictions to all federal grantees and adding new data submission [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live